Facts of INLYTA (Axitinib) Tablets ?
- Medicine Name: INLYTA
- Generic Name: Axitinib
- Approval Date: 09/06/2013
- Company Name: Pfizer
- Available as (Form & Strength): 1 mg and 5 mg tablets
INLYTA is indicated for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].